Company
Beam Therapeutics Inc. (BEAM)
Standardized SEC financial data for Beam Therapeutics Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001745999 · NASDAQ · Biological Products, (No Diagnostic Substances).
Operating margin
-274.6%
Net margin
-57.2%
Revenue growth (YoY)
120.0%
Return on equity
-6.5%
Free cash flow
-$360.0M
Current ratio
13.09×
EPS (diluted)
$-0.81
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $24K | $51.8M | $60.9M | $377.7M | $63.5M | $139.7M |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $299.7M | $965.6M | $1.10B | $1.20B | $850.7M | $1.20B |
| Total current assets |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$95.7M | -$66.3M | $22.5M | -$149.2M | -$347.2M | -$345.1M |
| Capital expenditures |
Get BEAM data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/BEAM/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/BEAM/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"